This list is an analysis based on recent market events. It's not an investment recommendation.
About
Aelis Farma SA, a clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France. The company is developing signaling-specific inhibitors of the CB1 receptors, such as AEF0117, a drug candidate, which is in Phase 2b clinical trials for the treatment of the harmful effects of excessive cannabis use; and AEF0217, a drug candidate, which is in phase II clinical trials to treat cognitive deficits observed in down syndrome, as well as other cognitive impairments. Aelis Farma SA was incorporated in 2013 and is headquartered in Bordeaux, France.
The current price of AELIS.PA is €1.25 EUR — it has decreased by -2.19% in the past 24 hours. Watch Aelis Farma. stock price performance more closely on the chart.
What is Aelis Farma. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aelis Farma. stocks are traded under the ticker AELIS.PA.
Is Aelis Farma. stock price growing?▼
AELIS.PA stock has fallen by -2.5% compared to the previous week, the month change is a -1.57% fall, over the last year Aelis Farma. has showed a +0% increase.
What is Aelis Farma. market cap?▼
Today Aelis Farma. has the market capitalization of 17.13M
What is Aelis Farma. revenue for the last year?▼
Aelis Farma. revenue for the last year amounts to 5.36M EUR.
What is Aelis Farma. net income for the last year?▼
AELIS.PA net income for the last year is -14.91M EUR.
How many employees does Aelis Farma. have?▼
As of April 29, 2026, the company has 24 employees.
In which sector is Aelis Farma. located?▼
Aelis Farma. operates in the Health & Wellness sector.
When did Aelis Farma. complete a stock split?▼
Aelis Farma. has not had any recent stock splits.
Where is Aelis Farma. headquartered?▼
Aelis Farma. is headquartered in Bordeaux, France.